|
| Press Releases |
|
 |
|
| Wednesday, March 25, 2026 |
|
|
Hengrui Pharma Announces Strong 2025 Annual Results |
| On March 25, 2026, Hengrui Pharma (600276.SH; 01276.HK) announced robust financial results for the full year 2025, fueled by its dual strategy of innovation and globalization. more info >> |
|
|
營收淨利再創新高！恒瑞醫藥2025年營收316.29億元 同比增長13.02% 淨利77.11億元 同比增長21.69% |
| 3月25日，恒瑞醫藥發佈2025年年度報告。報告期內，公司堅持「科技創新+國際化」雙輪驅動戰略，實現業績持續增長，營收和淨利均再創新高。 more info >> |
|
| Wednesday, May 28, 2025 |
|
|
Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Wrap Up Successfully |
| The fifth Asia Summit on Global Health (ASGH) and the 16th Hong Kong International Medical and Healthcare Fair (Medical Fair), both organised by the Hong Kong Trade Development Council (HKTDC), have drawn to a successful close. As flagship events of International Healthcare Week (IHW), both ASGH and the Medical Fair brought global healthcare stakeholders together, including government officials and organisations, research pioneers, investors, and business leaders. more info >> |
|
| Saturday, November 9, 2019 |
|
|
Novaliq and Jiangsu Hengrui Medicine Announce a Collaboration for Investigational NOV03 and CyclASol in China |
| Novaliq GmbH, a pharmaceutical company focusing on first- and best-in-class ocular therapeutics, and Jiangsu Hengrui Medicine Co., Ltd. (SSE: 600276), a fully integrated biopharmaceutical company based in China, announced the closing of an exclusive license agreement to develop, manufacture and commercialize the innovative, water-free drugs NOV03 and CyclASol(R) for the treatment of dry eye disease in the People's Republic of China (mainland China, Hong Kong, Macau and Taiwan). more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Aleen Inc. Introduces Biomarker Data Layer in Personal Wellness Account
Mar 25, 2026 23:28 HKT/SGT
|
|
|
Hengrui Pharma Announces Strong 2025 Annual Results
Mar 25, 2026 23:15 HKT/SGT
|
|
|
營收淨利再創新高！恒瑞醫藥2025年營收316.29億元 同比增長13.02% 淨利77.11億元 同比增長21.69%
Mar 25, 2026 22:55 HKT/SGT
|
|
|
Everbright Grand China Assets Recorded Revenue of RMB49.9 Million in 2025
Mar 25, 2026 22:39 HKT/SGT
|
|
|
光大永年2025年全年收入為人民幣49.9百萬元 全年股息為每股人民幣1.77分
Mar 25, 2026 22:31 HKT/SGT
|
|
|
国元国际：亿胜生物科技价值被低估 建议积极关注
Mar 25, 2026 22:02 HKT/SGT
|
|
|
國元國際：億勝生物科技價值被低估 建議積極關注
Mar 25, 2026 21:33 HKT/SGT
|
|
|
鋰測量 MR 技術供應商 NanoNord 攜手 DLE 領域領導者 ElectraLith 拓展業務，此舉緊隨丹麥王室對澳洲的國事訪問之後
Mar 25, 2026 20:30 HKT/SGT
|
|
|
锂测量MR技术供应商NanoNord与DLE领域领军企业ElectraLith拓展业务合作，此前丹麦代表团刚结束对澳大利亚的国事访问
Mar 25, 2026 20:30 HKT/SGT
|
|
|
Lithium Measurement MR-Technology Provider NanoNord Expands Business with DLE Leader ElectraLith, Following Danish State Visit to Australia
Mar 25, 2026 20:30 HKT/SGT
|
|
|
Adyton Reports 6.60g/t Au, 2.44% Cu and 39.8g/t Ag Within 164m @ 0.82g/t AuEq Including 53m at 1.60g/t AuEq Within 164m at 0.82g/t AuEq from the Northeastern Extension Target, Feni Island
Mar 25, 2026 19:29 HKT/SGT
|
|
|
ソニー・ホンダモビリティの事業方針の見直しについて
Mar 25, 2026 18:20: JST
|
|
|
Emperor Watch & Jewellery Limited Announces 2025 Annual Results
Mar 25, 2026 18:06 HKT/SGT
|
|
|
英皇鐘錶珠寶有限公司公佈2025年全年業績 淨利潤上升約68% 末期股息增加超過150%
Mar 25, 2026 18:06 HKT/SGT
|
|
|
英皇钟表珠宝有限公司公布2025年全年业绩 净利润上升约68% 末期股息增加超过150%
Mar 25, 2026 18:06 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
